Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Biotechnology company CytoDyn Inc. announced that the first patient has been dosed in its Expanded Access Program for Leronlimab targeting triple-negative breast cancer.

Biotechnology company CytoDyn Inc. announced that the first patient has been dosed in its Expanded Access Program for Leronlimab targeting triple-negative breast cancer.

老虎证券老虎证券2026/04/27 12:43
Show original
This development marks a critical step forward in the clinical application of this experimental therapy for specific patient groups.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The Fed votes to approve stress test reforms, with Wall Street banks achieving a sweeping victory.

The Federal Reserve on Wednesday voted to approve the final rules for its annual stress tests, marking a major victory for large Wall Street banks.

智通财经•2026/09/30 13:46
The Fed votes to approve stress test reforms, with Wall Street banks achieving a sweeping victory.